These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10509543)

  • 1. Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis.
    Sato A; Funder JW; Saruta T
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):867-73. PubMed ID: 10509543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
    Sato A; Suzuki Y; Saruta T
    Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of imidapril on left ventricular mass in chronic hemodialysis patients.
    Matsumoto N; Ishimitsu T; Okamura A; Seta H; Takahashi M; Matsuoka H
    Hypertens Res; 2006 Apr; 29(4):253-60. PubMed ID: 16778332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis.
    Steigerwalt S; Zafar A; Mesiha N; Gardin J; Provenzano R
    Am J Nephrol; 2007; 27(2):159-63. PubMed ID: 17317951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.
    Catena C; Verheyen ND; Url-Michitsch M; Kraigher-Krainer E; Colussi G; Pilz S; Tomaschitz A; Pieske B; Sechi LA
    Am J Hypertens; 2016 Mar; 29(3):303-10. PubMed ID: 26163660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
    du Cailar G; Fesler P; Ribstein J; Mimran A
    Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetric and asymmetric left ventricular hypertrophy in patients with end-stage renal failure on long-term hemodialysis.
    Straumann E; Bertel O; Meyer B; Weiss P; Misteli M; Blumberg A; Jenzer H
    Clin Cardiol; 1998 Sep; 21(9):672-8. PubMed ID: 9755385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients.
    Feniman De Stefano GM; Zanati-Basan SG; De Stefano LM; Silva VR; Xavier PS; Barretti P; da Silva Franco RJ; Caramori JC; Martin LC
    Ther Adv Cardiovasc Dis; 2016 Oct; 10(5):304-13. PubMed ID: 27122492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension and left ventricular hypertrophy in hemodialysis patients.
    Paoletti E; Cannella G
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S46-51. PubMed ID: 12227726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.
    Schunkert H; Hense HW; Muscholl M; Luchner A; Kürzinger S; Danser AH; Riegger GA
    Heart; 1997 Jan; 77(1):24-31. PubMed ID: 9038690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
    Wang AY; Li PK; Lui SF; Sanderson JE
    Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
    BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma aldosterone concentrations are not related to the degree of angiotensin-converting enzyme inhibition in essential hypertensive patients.
    Sato A; Suzuki Y; Shibata H; Saruta T
    Hypertens Res; 2000 Jan; 23(1):25-31. PubMed ID: 10737132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease.
    Blacher J; Demuth K; Guerin AP; Vadez C; Moatti N; Safar ME; London GM
    J Nephrol; 1999; 12(4):248-55. PubMed ID: 10493568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.